000291663 001__ 291663
000291663 005__ 20241031115012.0
000291663 0247_ $$2doi$$a10.3389/fonc.2024.1397790
000291663 0247_ $$2pmid$$apmid:39011478
000291663 0247_ $$2pmc$$apmc:PMC11246987
000291663 037__ $$aDKFZ-2024-01484
000291663 041__ $$aEnglish
000291663 082__ $$a610
000291663 1001_ $$aSallam, Mohamed$$b0
000291663 245__ $$aBibliometric and scientometric analysis of PSMA-targeted radiotheranostics: knowledge mapping and global standing.
000291663 260__ $$aLausanne$$bFrontiers Media$$c2024
000291663 3367_ $$2DRIVER$$aarticle
000291663 3367_ $$2DataCite$$aOutput Types/Journal article
000291663 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1721653906_17462$$xReview Article
000291663 3367_ $$2BibTeX$$aARTICLE
000291663 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000291663 3367_ $$00$$2EndNote$$aJournal Article
000291663 500__ $$a#LA:E270#
000291663 520__ $$aBibliometric and scientometric analyses provide a structured approach to large amounts of data, enabling the prediction of research theme trends over time, the detection of shifts in the boundaries of disciplines, and the identification of the most productive countries, institutions and scholars. In the context of prostate-specific membrane antigen (PSMA)-targeted radiotheranostics, no bibliometric or scientometric analysis has been published thus far. Therefore, this study was conducted to identify key contributors to the literature, assess the global scientific production of related research, and possibly predict future development patterns.Scientometrics and bibliometrics were utilized to analyze the current body of knowledge while tracking its evolution to support scientific decision-making comprehensively and systematically. Science mapping techniques were employed to visualize research activities. Two different tools, Tableau and VOSviewer, were utilized, with VOSviewer being deemed the most suitable for the research objectives. The Web of Science (WoS) was used as the principal database for the searches.Through the search process over a period of 30 years (January 1993-January 2023), 694 original studies in the English language were subjected to comprehensive analysis. By employing bibliometric and scientometric methods, multiple networks were created that mapped various concepts, such as publication trends, leading countries, cocitations, coauthorship among researchers and scientists, as well as coauthorship among organizations and funding agencies. This study revealed the evolutionary patterns, trends, outliers, and key players in the PSMA field, which enabled a more nuanced understanding of the research landscape.This research contributes to the enrichment of knowledge on PSMA-targeted radiotheranostics through detailed global bibliometric and scientometric analyses. It stresses the necessity for the development of communication platforms, the establishment of supportive infrastructures, and the implementation of proactive solutions to address emerging challenges. This study offers a significant resource for delineating effective strategies and identifying prominent funding bodies essential for continuous advancements in the field of PSMA-based diagnosis and therapy for prostate cancer. It is vital to sustain this momentum to ensure further progress in this pioneering area.
000291663 536__ $$0G:(DE-HGF)POF4-315$$a315 - Bildgebung und Radioonkologie (POF4-315)$$cPOF4-315$$fPOF IV$$x0
000291663 588__ $$aDataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
000291663 650_7 $$2Other$$aPSMA pioneers
000291663 650_7 $$2Other$$aPSMA-targeted radiotheranostics
000291663 650_7 $$2Other$$abibliometric and scientometrics
000291663 650_7 $$2Other$$aleading PSMA
000291663 650_7 $$2Other$$aprostate cancer
000291663 650_7 $$2Other$$aprostate-specific membrane antigen (PSMA)
000291663 7001_ $$aMohammadi, Mahan$$b1
000291663 7001_ $$aSainsbury, Frank$$b2
000291663 7001_ $$aNguyen, Nam-Trung$$b3
000291663 7001_ $$aKimizuka, Nobuo$$b4
000291663 7001_ $$aMuyldermans, Serge$$b5
000291663 7001_ $$0P:(DE-He78)0f034e05cefb010f991ef8b96009d95c$$aBenesova-Schäfer, Martina$$b6$$eLast author$$udkfz
000291663 773__ $$0PERI:(DE-600)2649216-7$$a10.3389/fonc.2024.1397790$$gVol. 14, p. 1397790$$p1397790$$tFrontiers in oncology$$v14$$x2234-943X$$y2024
000291663 8564_ $$uhttps://inrepo02.dkfz.de/record/291663/files/fonc-14-1397790.pdf
000291663 8564_ $$uhttps://inrepo02.dkfz.de/record/291663/files/fonc-14-1397790.pdf?subformat=pdfa$$xpdfa
000291663 909CO $$ooai:inrepo02.dkfz.de:291663$$pVDB
000291663 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)0f034e05cefb010f991ef8b96009d95c$$aDeutsches Krebsforschungszentrum$$b6$$kDKFZ
000291663 9131_ $$0G:(DE-HGF)POF4-315$$1G:(DE-HGF)POF4-310$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vBildgebung und Radioonkologie$$x0
000291663 9141_ $$y2024
000291663 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bFRONT ONCOL : 2022$$d2023-10-26
000291663 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2023-10-26
000291663 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2023-10-26
000291663 915__ $$0StatID:(DE-HGF)0320$$2StatID$$aDBCoverage$$bPubMed Central$$d2023-10-26
000291663 915__ $$0StatID:(DE-HGF)0501$$2StatID$$aDBCoverage$$bDOAJ Seal$$d2021-05-11T13:25:45Z
000291663 915__ $$0StatID:(DE-HGF)0500$$2StatID$$aDBCoverage$$bDOAJ$$d2021-05-11T13:25:45Z
000291663 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bDOAJ : Anonymous peer review$$d2021-05-11T13:25:45Z
000291663 915__ $$0LIC:(DE-HGF)CCBYNV$$2V:(DE-HGF)$$aCreative Commons Attribution CC BY (No Version)$$bDOAJ$$d2021-05-11T13:25:45Z
000291663 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2023-10-26
000291663 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2023-10-26
000291663 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2023-10-26
000291663 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2023-10-26
000291663 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine$$d2023-10-26
000291663 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5$$d2023-10-26
000291663 915__ $$0StatID:(DE-HGF)0561$$2StatID$$aArticle Processing Charges$$d2023-10-26
000291663 915__ $$0StatID:(DE-HGF)0700$$2StatID$$aFees$$d2023-10-26
000291663 9202_ $$0I:(DE-He78)E270-20160331$$kE270$$lTranslationale Radiotheranostik$$x0
000291663 9201_ $$0I:(DE-He78)E270-20160331$$kE270$$lTranslationale Radiotheranostik$$x0
000291663 980__ $$ajournal
000291663 980__ $$aVDB
000291663 980__ $$aI:(DE-He78)E270-20160331
000291663 980__ $$aUNRESTRICTED